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Improving Outcome Prediction Accuracy of Carotid Endarterectomy
(CEA) in Asymptomatic Patients Using a Novel Frailty Risk Score
(FRS)>
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Richard Amdur. George Washington University, Wash, D.C.
Objectives: CEA in asymptomatic patients is recommended only
when postoperative complications and mortality are kept low; but predicting
CEA complications in a speciﬁc patient remains elusive. To better predict
30-day postoperative outcomes, we calculated a novel point-weight ordinal
Frailty Risk Score (FRS) by an analysis of 20 preoperative risk factors based
on their individual odds ratios (ORs) as predictors of postoperative compli-
cations using all vascular surgery cases in the 2005 to 2011 American
College of Surgeons National Surgical Quality Improvement Program
(ACS-NSQIP) database (n ¼ 121,015).
Methods: To compare the predictive value of this calculated FRS with
that of patient demographics and surgical variables alone, we examined the
predictive contribution value of ﬁve levels of FRS on four outcomes (stroke,
myocardial infarction [MI], and mortality), and a composite of the three
outcomes in all primary asymptomatic CEAs in the 2005 to 2011 ACS-
NSQIP database (n ¼ 39,859).
Results: Thirty-day mortality occurred in 273 patients (0.7%), stroke
in 527 (1.3%), MI in 301 (0.8%), and the composite outcome was positive
in 1008 (2.5%). We found that by itself, the FRS level was strongly and
signiﬁcantly associated with all four outcomes (Table). For stroke, we
used only three levels of frailty because the stroke rate no longer increased
after this point, and found that for the lowest vs highest frailty levels, the
rate of stroke was 1.1% vs 2.4% (P < .0001). Percentage of patients that
were positive for the composite outcome was 1.7% in lowest vs 15.2% in
the highest FRS group (P < .0001).
Conclusions: An easy-to-calculate FRS can help stratify risk based on
preoperative patient characteristics and will help to identify asymptomatic
patients for whom CEA is risky.Table. Percentage of patients positive for each outcome by frailty level
Frailty
level
Death, Stroke, MI, Composite outcome,
% (95% CI) % (95% CI) % (95% CI) % (95% CI)
1 0.2 (0.2-0.3) 0.2 (0.2-0.3) 0.4 (0.3-0.5) 1.7 (1.5-1.9)
2 0.7 (0.6-0.9) 1.3 (1.2-1.5) 0.8 (0.7-0.9) 2.6 (2.4-2.8)
3 1.6 (1.2-2.0) 2.4 (1.9-2.9) 1.7 (1.3-2.1) 5.1 (4.4-5.8)
4 3.0 (1.7-4.4) 1.6 (0.6-2.6) 2.2 (1.1-3.4) 6.4 (4.5. 8.3)
5 10.7 (5.0-16.4) 1.8 (0-4.2) 5.4 (1.2-9.5) 15.2 (8.5-21.8)
CI, Conﬁdence interval; MI, myocardial infarction.Disclosures: A. N. Sidawy: Nothing to disclose; R. F. Neville: Nothing to
disclose; B. N. Nguyen: Nothing to disclose; G. Panjrath: Nothing to
disclose; R. Amdur: Nothing to disclose
Development of a Successful Follow-Up Program for Patients After
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Objectives: Patients treated with endovascular abdominal aortic aneu-
rysm (AAA) repair (EVAR) require lifelong follow-up. Although a variety of
post-EVAR surveillance protocols have been suggested, adherence to
follow-up outside of industry-funded clinical trials has been challenging.
We aim to describe an effective system for EVAR surveillance over 10 years
that results in exceptional follow-up.
Methods: From 2003 to 2013, 225 EVARs were performed for elec-
tive, symptomatic, or ruptured AAA using a variety of commercially avail-
able devices at a single, rural, academic center. After repair, all patients>Eastern Vascular Society
yNew England Society for Vascular Surgerywere followed up every 6 to 12 months with clinic visits and imaging
(computed tomography or ultrasound). All patients were entered into the
Vascular Quality Initiative database, which was audited quarterly by hospital
quality personnel. At the time of the audit, a list of EVAR patients due for
imaging was generated and forwarded to a dedicated vascular clinic nurse
who arranged imaging and clinic visits for those missing follow-up. Mortal-
ity and rationale for incomplete follow-up were recorded in a prospective
follow-up database.
Results: In hospital mortality was 0.9% for elective or symptomatic
AAA and 25% for ruptured AAA. Most (99%) were discharged to home
and 98% remained independent at 1 year. All-cause mortality was 7.2%,
25.4%, 44.9%, and 68.1% at 1, 3, 5, and 10 years. Median follow-up was
3.7 years. Using the above protocol resulted in comprehensive follow-up of
patients at 1, 3, and 5 years of 96%, 92%, and 84%, respectively. A signiﬁcant
drop off in adherence to follow-up was noted at 9 years. Resources required
to accomplish this were minimal, with <0.05 nursing full-time equivalents
and <0.05 full-time equivalents for hospital quality personnel (Fig).
Conclusions: EVAR has acknowledged rates of short-term and long-
term failure so that implantation of the stent graft is only part of successful
treatment of AAA. The follow-up program we describe is comparable to
that achieved in industry-sponsored trials. With many groups currently
participating in the Vascular Quality Initiative, the methodology presented
here is reproducible.
Fig. Follow-up of endovascular abdominal aortic aneurysm (AAA) repair
(EVAR) patients.
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Venous Thromboembolism in High-Risk Patients: Are We Doing
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Objectives: Hospital-acquired venous thromboembolism (VTE) is a
costly quality and safety indicator thought to be preventable. Embedding
risk-assessment models into the electronic medical record (EMR) to in-
crease appropriate use of VTE prophylaxis for low-risk, medium-risk, and
high-risk patients is one strategy to decrease VTE events. We proposed
that high-risk patients receiving prophylaxis with mechanical and pharmaco-
logic methods would have a lower VTE rate than those who received one
prophylactic modality or none.
Methods: All medical and surgical patients admitted from October 1,
2011, to October 31, 2012 were reviewed. The EMR was reviewed for the
VTE risk-assessment score determined upon admission, the type of VTE
prophylaxis used, and the rate of hospital-acquired VTE by risk category.
Results: Of the 24,960 patients admitted, 175 (0.71%) developed
VTE during their hospital stay. At the time of admission, 16.7% (4164)
were assigned to the high-risk group, of which 71.3% (2967) received me-
chanical and pharmacologic prophylaxis, 13.0% (542) mechanical alone,>Eastern Vascular Society
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dence of VTE in the high-risk group was 1.3% (54) compared with 0.9%
(88) and 0.2% (16) in the medium-risk and low-risk groups, respectively.
Of the 54 high-risk patients who developed VTE, 48 (88%) received appro-
priate prophylaxis as assigned by the risk-assessment model. The incidence
of VTE in the high-risk group was greater when mechanical and pharmaco-
logic prophylaxis were both used (50.0%) compared with pharmacologic
alone (3.7%), mechanical alone (35.2%), or no prophylaxis (11.1%; P ¼
.05; Fig).
Conclusions: Hospital-acquired VTE develops in high-risk patients
despite appropriate risk assessment, identiﬁcation, and prophylaxis with
pharmacologic and mechanical methods. Further consideration for more
aggressive prophylaxis should be given to this high-risk patient population
for VTE prevention.Fig. Incidence of venous thromboembolism (VTE) in all patients based on
prophylaxis.
Table. Comparison of patients treated with endovascular
revascularization (ER) and patients treated with open revascularization
(OR)
Variable ER OR P
Age, mean years 73 6 8 64 6 11 .0003
Comorbidities, % 62 38 .0026
Vessels treated 1.23 6 0.42 1.59 6 0.5 .0032
Restenosis, % 25 4 .029
Hospital LOS, days 5 6 6 13 6 10 .012
Mortality, % 4.8 4 .868
LOS, Length of stay.Disclosures: A. C. Ring: Nothing to disclose; F. Aziz: Nothing to disclose;
M. J. Beck: Nothing to disclose; A. B. Reed: Nothing to disclose
Prospective Cost Analysis and Implications of Wound Complications
in Lower Extremity Vascular Surgery Proceduresy
Louis L. Nguyen,1 Gregory A. Leya,2 Nathanael D. Hevelone,1 Neal R.
Barshes,3 Mark C. Myers,4 Allen D. Hamdan,4 Michael Belkin,1 Charles
K. Ozaki1. 1Brigham and Women’s Hospital, Boston, Mass; 2Harvard
Medical School, Boston, Mass; 3Michael DeBakey Veteran’s Affairs
Medical Center, Houston, Tex; 4Beth Israel Deaconess Hospital, Boston,
Mass
Objectives: Wound complications (WCs), such as surgical site infec-
tion, wound dehiscence, hematoma, and seroma after surgery cause signif-
icant morbidity and require additional resources to treat. We sought to
quantify the marginal cost of WCs in patients undergoing open lower ex-
tremity vascular procedures.
Methods: Hospital administrative accounting cost data from a single
tertiary institution were analyzed in patients enrolled in a prospective,
randomized trial testing two postoperative wound dressings (gauze vs silver-
coated alginate). A Wilcoxon rank sum test was used to assess the incremen-
tal cost of WCs at 30 days.
Results: Of the 224 patients who underwent lower extremity
vascular surgery procedures, 61 (27.2%) developed WC, 40 (17.9%) of
which were a surgical site infection. The mean incremental cost of
WCs was $11,973, reﬂecting a 35% higher cost than non-WC patients
(P ¼ .0112). Patients with WCs had a longer mean index length of
stay (8.2 vs 6.0 days, P ¼ .0025), a higher rate of 30-day readmissions
(23% vs 6%, P ¼ .0001), and a greater mean cumulative 30-day length
of stay (10.1 vs 6.2 days, P ¼ .0001). The tested dressings showed no
efﬁcacy or cost differences.
Conclusions: WCs remain a frequent sequela of open lower extremity
vascular surgery, with signiﬁcant cost and resource utilization. Although the
tested dressing did not demonstrate efﬁcacy in reducing WCs, there remains
potential cost savings for new and effective products or patient care quality
improvements to capture.
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Chronic Mesenteric Ischemia: Outcome Analysis and Predictors of
Endovascular Failurey
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Objectives: Outcomes of open (OR) and endovascular revasculariza-
tion (ER) for chronic mesenteric ischemia (CMI) were analyzed to identify
predictors of endovascular failure.
Methods: Amulticenter, retrospective studywasperformedof all consec-
utive patients with CMI (151 patients/254 vessels) treated from2008 to 2012.
Demographics, comorbidities, etiology, and treatment modalities were
compared. Outcomes included technical success, restenosis requiring reinter-
vention, complications, mortality, and hospital length of stay (LOS).
Results: A total of 126 patients were treated with ER (83%) and 25 pa-
tients with OR (17%). Average follow-up period was 15.5 months. Overall
mortality was 4.6% (7 of 151). A comparison between the two groups is re-
ported in the Table. Among patients treated with ER, 14.3% developed tech-
nical and perfusion-related complications vs 20% in the OR group (P¼ .464).
A subgroup analysis showed patients with ER requiring reinterventions had a
higher incidence of long lesions>2 cm on angiography (55% vs 7%, P< .05).
Patients crossing over from ER to OR had a signiﬁcantly higher mortality
comparedwithERgroup-only (17.6% [3of 17] vs 2.5% [3of 119]),P¼ .007).
Conclusions: ER has similar mortality and shorter hospitalization but
higher rate of restenosis requiring reintervention compared with OR. Pa-
tients with ER who require reintervention appear to have longer lesions
on angiography. Patients who crossed over from ER had a higher mortality
than primary OR or ER patients. These ﬁndings may guide treatment selec-
tion in patients with CMI undergoing ER or OR.Disclosures: N. Zacharias: Nothing to disclose; S. Eghbalieh: Nothing
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Objectives: Recent initiatives have created incentives to reduce length
of stay (LOS) and decrease readmission rates. We sought to elucidate the
risk factors for both outcomes and to clarify the relationship between
them in patients undergoing lower extremity bypass (LEB).
Methods: Peripheral arterial disease patients (PAD) who underwent
LEB were identiﬁed from the 2007 to 2010 California State Inpatient Data-
base. Logarithmically transformed LOS and risk factors were analyzed using
linear regression. Risk factors for 30-day readmission were analyzed using
logistic regression.
Results: Of 6558 patients who underwent LEB, 1541(24%) were
readmitted. The average index LOS was 8.3 days for those who wereyNew England Society for Vascular Surgery
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